Sværvægter er blevet markant bedre til at tjene penge

GN Store Nords kvartalsregnskab viser en tiltrængt evne til at tjene penge

By Jesper Lesager

May 2, 2024 3:35 PM

Det har været to hårde år for GN Store Nord. Evnen til at tjene penge faldt som en sten i vandet i 2022 og 2023.

Men skal man tro kvartalsregnskabet, som blev offentliggjort torsdag morgen, ser udviklingen ud til at være vendt.

- Vi er meget tilfredse med at starte året stærkt, siger adm. direktør Peter Karlströmer til MedTechNews.

1 month free trial

Get access to all content on Life Science Focus

No commitment or card information required

Try Life Science Focus now

Already a subscriber? Log In

Applies to personal subscription only.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.

Yes please, I would like to receive Life Science Focuss newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Focus Read cookie and data policy.

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}

Sværvægter er blevet markant bedre til at tjene penge

Spago plans stock market exit to facilitate fundraising

Pfizer job cuts reported at several manufacturing sites

Inossia raises SEK 88m – targets US approval

Moderna plunged by double digits after study data leaked

EQT leads €9.6bn buyout of Qiagen

AstraZeneca wins new FDA approval for serious kidney disease

Effektiv flödesmätning för vatten- och avloppssystem med FLUXUS WD

Smartare kvalitetskontroll med Zebra NS42 från OEM Automatic

QAdvis & Scandinavian CRO are now Aurevia

Pumphuvudkonfiguration: Optimera flöde och vakuumprestanda

From innovation to compliance: Medtech Compliance Forum by Aurevia & RAPS explores health technology

Integrated Clinical and Regulatory Support for Oncology Trials

Explore the ZEISS Innovation Summit 2026

Your UKRP Partner for Medical Device Market Access in the UK

Kostnadseffektiv och driftsäker nivåmätning med Rosemount 1208

Medical Device Software Process Design: Why IEC 62304 Matters

Kostnadseffektiv automation för framtidens företag

Your Partner for Clinical Study Submissions and Regulatory Interactions